Posters

iPeptides: An Extensible Python Toolkit for 3D Modeling, Enumeration and QSAR of Peptides25th EuroQSAR 2026September 2026Code 26020View poster Discovery and Characterization of a Brain-Penetrant SHP2 InhibitorDDIP 2026September 2026Code 26019View poster Mitigating Pyroglutamate in Microwave-Assisted SPPS: Side-Reaction Control and Sequence–Structure Influence19th Naples Workshop on Bioactive Peptides 2026June 2026Code 26016View poster C3PO: Complex 3D Patient Organoids for Preclinical Drug Testing in Brain TumorsPRIM-TECH3R & BaCell 2026June 2026Code 26014-15View poster A Functional Human iPSC-Derived Blood–Brain Barrier Model to Predict CNS Drug PenetrationPRIM-TECH3RJune 2026Code 26013View poster Putting DMPK Where It Matters Most: Enabling Exposure-Driven Lead SelectionDiscovery & Development Europe 2026June 2026Code 26012View poster Discovery and In Vitro Characterization of Novel Coronavirus NSP13 Helicase InhibitorsDiscovery & Development Europe 2026June 2026Code 26011View poster Focused Multiparameter Optimization to Convert Potent Allosteric SHP2 Inhibitors into Brain-Penetrant CandidatesNMCS 2026June 2026Code 26010View poster One-Pot Solution-Phase Strategy for the Synthesis of Bicyclic Peptides Using the T3P/[Pd(PPh₃)₄] SystemTIDES 2026May 2026Code 26009View poster Phenotypic-Based Discovery of Zika Virus Protease Inhibitors with Potent Cellular and In Vivo ActivityICAR 2026April 2026Code 26008View poster Novel Small-Molecule Inhibitors of Coronavirus Discontinuous Transcription Identified through Integrated Screening ApproachesICAR 2026April 2026Code 26007View poster C3PO: Complex 3D Patient Organoids for Preclinical Drug Testing in Brain TumorsAACR 2026April 2026Code 26006View poster Electrophile-First Approach Enables Rapid Identification of ATP-Competitive Inhibitors of Werner HelicaseDrug Discovery Chemistry 2026April 2026Code 26005View poster Establishment of an NMR Workflow to Identify and Validate MutSβ and/or MutSβ-DNA Binding InhibitorsCHDI Annual Conference 2026February 2026Code 26003View poster Phenotypic Screen to Identify Inhibitors of Coronavirus Discontinuous TranscriptionSLAS 2026February 2026Code 26002View poster Identification of Covalent Inhibitors Targeting NSP13 via Integrated Biochemical and Chemoproteomics ApproachesSLAS 2026February 2026Code 26001View poster High-Throughput Automated Screening for Robust Peptide Bioanalysis and Protein Binding EvaluationEuropean Bioanalysis Forum Open Symposium (EBF) 2025November 2025Code 25025View poster Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) Platform to Support Preclinical Studies in Peptide Radioligand TherapyTIDES Europe 2025November 2025Code 25024View poster Phenotypic Screen to Identify Inhibitors of Coronavirus Discontinuous TranscriptionDrug Discovery ELRIG 2025October 2025Code 25023View poster Identification of Hit Inhibitors of SARS-CoV-2 NSP13 Helicase through Comprehensive Screening CascadeDrug Discovery ELRIG 2025October 2025Code 25022View poster Integrated Platforms for Rapid Identification of PROTACs and Covalent FragmentsXXIX National Meeting on Med Chem 2025September 2025Code 25021View poster R2R01: A Potent Long-Acting RXFP1 Peptide Agonist in Phase 2 Development for Cardiovascular and Renal DisordersBoulder Peptide Symposium 2025September 2025Code 25020View poster From Chimeric Fragments to Functional Degraders: A Streamlined Platform for PROTAC DiscoveryEFMC 2025September 2025Code 25019View poster Identification of SARS-CoV-2 Helicase Inhibitors Part 2EFMC 2025September 2025Code 25018_02View poster Identification of SARS-CoV-2 Helicase Inhibitors Part 1EFMC 2025September 2025Code 25018_01View poster One-Pot Solution-Phase Strategy for the Synthesis of Bicyclic Peptides Using the T3P/[Pd(PPh₃)₄] SystemEPSC 2025August 2025Code 25017View poster Generation and Biophysical Characterization of New α-Nsp13 Helicase mAbs, as a Powerful Tool for Studying SARS-CoV-2 Replication and Therapeutic TargetingEBSA 2025July 2025Code 25016View poster C3PO: Complex 3D Patient Organoids for Preclinical Compound Testing in Brain TumorsBaCell 3D 2025June 2025Code 25015View poster A Platform for Comprehensive CRISPR/Cas9 Genome Editing in Preclinical Research and Drug DiscoverySIBBM Frontiers in Molecular Biology 2025June 2025Code 25014View poster Identification and Biophysical Assessment of mAb AM E3, an Innovative α-TLSPR ADC Candidate Aimed at Treating TLSPR/CRLF2-Rearranged Ph-like B-ALLAntibody Engineering & Therapeutics Europe 2025June 2025Code 25013View poster Sequence-Driven Strategies for Optimizing ADME Properties of Therapeutic PeptidesTIDES 2025May 2025Code 25012View poster AM E3-SG3249, a First-in-Class α-CRLF2 Antibody-Drug Conjugate for the Treatment of CRLF2-Rearranged Ph-like B-ALLAACR 2025April 2025Code 25011View poster Advancing Treatment for Brain Tumors and Metastases with I-1000233, a Brain Permeable SHP2 InhibitorAACR 2025April 2025Code 25010View poster Establishment of a Stable Cell Line Containing a Tet-Off Regulated Episomal DNA Vector Expressing a SARS-CoV-2 RepliconEuropean Congress of Virology 2025April 2025Code 25009View poster High-Throughput Phenotypic Screening for the Development of Inhibitors Targeting Discontinuous Transcription in CoronavirusesEuropean Congress of Virology 2025April 2025Code 25008View poster Enabling Rapid Hit Identification: Integrated Platforms for PROTACs and Covalent FragmentsDrug Discovery Chemistry 2025April 2025Code 25005View poster High-Throughput Phenotypic Screening for the Development of Inhibitors Targeting Discontinuous Transcription in CoronavirusesICAR 2025March 2025Code 25003View poster Discovery of New Covalent Werner Helicase Inhibitors by High Throughput Screening ApproachSLAS 2025January 2025Code 25002View poster Discovery of I-1000233 and I-0436650, Two Potent, Selective SHP2 Allosteric InhibitorsSLAS 2025January 2025Code 25001View poster Covalent Inhibitors: How We Can Find Them in an Early Stage of a Drug Discovery ProgramSLAS 2024May 2024Code 24014View poster Development of Biochemical and Biophysical Assays for the Identification of Peptides Targeting the MLH1-MSH3 Protein-Protein InteractionDrug DiscoveryOctober 2024Code 24013View poster Compound Collection ManagementEFMC-ISMCSeptember 2024Code 24012View poster Design of a PROTAC Toolkit for the Identification of New Hits by Direct to Biology (D2B) ApproachEFMC-YMCSSeptember 2024Code 24011View poster Covalent Fragment-Based Drug Discovery Platform at IRBMEFMC-YMCSSeptember 2024Code 24010View poster SPR Technology for the Identification of New Therapeutic Agents from Phage Display LibrariesDIPIASeptember 2024Code 24009View poster Discovery of I-1000233, a Potent, Selective, and Brain Permeable SHP2 Allosteric InhibitorSICSeptember 2024Code 24008View poster Development of a New Bioanalytical Method for Selective Measurement of Wild-Type Huntingtin in Human Cerebrospinal FluidEHDN & Enroll-HDSeptember 2024Code 24007View poster Insights into the DNA Mismatch Repair System Exploiting a Frameshift Mutator Cell-Based Assay to Identify New Targets and Potential Treatments for Huntington’s DiseaseEHDN & Enroll-HDSeptember 2024Code 24006View poster
Back To Top
No results found...